VNDA Vanda Pharmaceuticals
- 6.180
- +0.030+0.49%
- 6.200
- +0.020+0.32%
Vanda Pharmaceuticals News
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Chrousos Phaedra
Vanda Pharmaceuticals | 8-K/A: Current report (Amendment)
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Honore Tage
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ward Anne Sempowski
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mitchell Stephen Ray
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DUGAN RICHARD W
Vanda Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | DEFA14A: Others
Vanda Pharmaceuticals | DEFA14A: Others
Vanda Pharmaceuticals | 10-Q: Quarterly report
Vanda Pharmaceuticals | 8-K: Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | 8-A12B/A: Registration of a class of securities on a national securities exchange (Amendment)
Vanda Pharmaceuticals | 8-K: Current report
Vanda Pharmaceuticals | ARS/A: Others
Analysis
Price Target
No Data
